North America Drug Delivery Market, By Type (Conventional, Advanced), Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others) – Industry Trends and Forecast to 2030.
North America Drug Delivery Market Analysis and Size
In recent years, the drug delivery market is expected to increase during the forecast period. As per WHO, chronic disease incidence is projected to rise by 57% by the end of 2020. Healthcare systems are focusing more on advanced drug delivery technologies, has risen promptly in response to the rise in chronic diseases. Additionally, there is a growing emphasis on product safety, efficacy, and patient-friendliness.
Data Bridge Market Research analyses a growth rate in the drug delivery market in the forecast period 2023-2030. The expected CAGR of the drug delivery market is tend to be around 6.90% in the mentioned forecast period. The market was valued at USD 720.57 billion in 2022, and it would grow up to USD 1228.85 million by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Drug Delivery Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Million, Volumes in Units, Pricing in USD
Type (Conventional, Advanced), Route of administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)
U.S., Canada and Mexico in North America
Market Players Covered
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Lilly (U.S.), 3M (U.S.), Bayer AG (Germany), Astellas Pharma Inc. (Japan), AbbVie Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan)
Drug delivery builds a therapeutic effect in a human's body by leading a drug to a certain targeted place. The safety and efficacy can be amplified by adjusting the rate, time, and release of the drug in the body. Drugs can be delivered in numerous ways, that includes oral, injectable, pulmonary, nasal, and other routes. The features of nanoparticles have been studied and used to develop drug delivery systems, making the drug distribution process more effective and time-saving.
North America Drug Delivery Market Dynamics
- Increase In The Occurrence Of Chronic Diseases
The increasing prevalence of chronic diseases is projected to propel the drug delivery market's growth. Obesity rates are increasing as a result of the rapid change in lifestyle, leading to a slew of chronic ailments such as diabetes and heart disease.
- Increasing Investment For Healthcare Infrastructure
A major factor prompting the growth rate of drug delivery market is the increasing healthcare expenditure that helps in improving its infrastructure.
Additionally, increasing initiatives by public and private organizations to spread awareness and technological advancement will enlarge the drug delivery market. Moreover, high disposable income and growing adoption of advanced drug administration systems will result in the expansion of drug delivery market.
- Growing Elderly Population
Life expectancy is increasing around the world, that has led to a surge in the aging population. This trend positively impacts the industry by growing the occurrence of the disease and creating per capita demand for its remedies. Thus, this population demands high use of muscle relaxants and boosts market growth.
- Increase In The Number Of Research And Development Activities
The market growth is driven by an increase in the number of research and development activities. This will provide advantageous opportunities for the drug delivery market growth. Along with this, increasing drug approvals and launch of innovative products will further boost the market growth rate.
- Rising Product Developments
Numerous product developments are initiated by several companies globally which are also accelerating the growth of market. For instance, in February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. told about the submission of a supplemental Biologics License Application (sBLA) to the U.S. FDA of DARZALEX along with Kyprolis and dexamethasone that is used to treat relapsed or refractory multiple myeloma.
- High Investment and Strict Regulatory Norms
The growth of the market is restricted by factors such as strict regulatory requirements and the risks associated with drug delivery systems. The use, separation, and development of raw materials for developing pharmaceutical and biopharmaceutical drugs demand professional and qualified personnel. Therefore, all these factors restrict the growth of the demand for the drugs.
This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In 2022, Sandoz, a Novartis division, declared the acquisition of a U.K.-based medical and drug delivery device company, Coalesce Product Development Limited. Sandoz acquired Coalesce's expertise and assets as part of the arrangement, that will help the company to expand its respiratory medication portfolio and improve patient access to high-quality and complex therapeutics.
North America Drug Delivery Market Scope
The drug delivery market is segmented on the basis of type, route of administration, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Route of Administration
- Oral Drug Delivery
- Pulmonary Drug Delivery
- Injectable Drug Delivery
- Opthalmic Drug Delivery
- Nasal Drug Delivery
- Topical Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
- Specialty Clinics
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
North America Drug Delivery Market Regional Analysis/Insights
The drug delivery market is analyzed and market size insights and trends are provided by product type, end-user, and distribution channel as referenced above.
The major countries covered in the drug delivery market report are the U.S., Canada and Mexico in North America.
The U.S. is dominating in the North America region due to the increase in the adoption rate of several new technological advancements in the drug delivery.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Drug Delivery Market Share Analysis
The drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to drug delivery market.
Key players operating in the drug delivery market include:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Merck & Co., Inc. (U.S.)
- Lilly (U.S.)
- 3M (U.S.)
- Bayer AG (Germany)
- Astellas Pharma Inc. (Japan)
- AbbVie Inc. (U.S.)
- Takeda Pharmaceutical Company Limited (Japan)